Hutch News

Reconsidering how to assess HSV-2 vaccine responses

Reconsidering how to assess HSV-2 vaccine responses

From the Corey lab, Vaccine and Infectious Disease Division
Science SpotlightSeptember 18, 2024
Biostatisticians draft blueprints for COVID-19 vax trials

Biostatisticians draft blueprints for COVID-19 vax trials

Hutch group applies skills honed during decades of HIV prevention trials to bring about safe and effective vaccines for a new pandemic
Hutch NewsFebruary 18, 2021